BAM66513 PF-562271 PF-562271 is a potent ATP-competitive FAK and proline-rich tyrosine kinase (Pyk2) inhibitor with potential antineoplastic and antiangiogenic activities. Quantity Price 5 mg 270.00 10 mg 470.00 50 mg 1270.00 200 mg 2970.00                 C27H26F3N7O6S2 MFCD16038299 99+%

BAM66514 SNS-032 SNS-032 (BMS-387032) is a potent and selective cyclin-dependent kinases (CDK) 9, 7 and 2 inhibitor with IC50 of 4, 62 and 38 nM for CDK9, CDK2/cyclin A and CDK7/Cyclin H. Quantity Price 5 mg 110.00 10 mg 170.00 50 mg 570.00 200 mg 1670.00                 C17H24N4O2S2 MFCD09833875 95+%

BAM66423 Tozasertib Tozasertib is the inhibitor of Aurora-A,-B,-C kinases with apparent inhibition constant values of 0.6,18,4.6 nM respectively. Quantity Price 25 mg 90.00 100 mg 170.00 300 mg 470.00                     C23H28N8OS 639089-54-6 98+% MFCD13185152

BAM66423 MK-0457 Tozasertib is the inhibitor of Aurora-A,-B,-C kinases with apparent inhibition constant values of 0.6,18,4.6 nM respectively. Quantity Price 25 mg 90.00 100 mg 170.00 300 mg 470.00                     C23H28N8OS 639089-54-6 98+% MFCD13185152

BAM66423 VX-680 Tozasertib is the inhibitor of Aurora-A,-B,-C kinases with apparent inhibition constant values of 0.6,18,4.6 nM respectively. Quantity Price 25 mg 90.00 100 mg 170.00 300 mg 470.00                     C23H28N8OS 639089-54-6 98+% MFCD13185152

[1/6]